Literature DB >> 19840750

Long-term outcome and quality of life in patients with Charcot foot.

Toni-Karri Pakarinen1, Heikki-Jussi Laine, Heikki Mäenpää, Pentti Mattila, Jorma Lahtela.   

Abstract

BACKGROUND: There is only sparse scientific data about the long-term effects of the Charcot foot on patients' lives and the clinical outcome. This study evaluates the long-term effects of diabetic Charcot foot.
METHODS: A cross-sectional follow-up study of consecutive series of patients with Charcot foot referred to the University Hospital Diabetic Foot and Ankle Clinic between 1991 and 2002.
RESULTS: Forty-one patients were referred with Charcot foot between 1991 and 2002. After an average follow-up of 8 years their overall mortality rate was 29% (12/41) and 29 patients (30 Charcot feet) have been followed more than 5 years. Sixty-seven percent of Charcot feet suffered at least one episode of ulceration and 50% (15/30) of affected feet had surgical treatment resulting in 29 operations. Simple exostectomy was successful in 62% of cases. The need for surgical management increased markedly 4 years after the diagnosis. Correct diagnosis within 3 months resulted in better functional outcome (AOFAS) and walking distance (p=0.006 and p=0.008, respectively). Lower SF-36 component scores in physical functioning, social functioning and general health perceptions were found when the study population was compared to the general population and chronically ill control subjects.
CONCLUSIONS: Diabetic Charcot foot decreases patient's physical functioning and general health but does not usually affect mental health. Surgical management is often required with an increase 4 years post-diagnosis. A delay of diagnosis of more than 3 months was found to adversely affect the quality of life and functional outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19840750     DOI: 10.1016/j.fas.2009.02.005

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  17 in total

1.  Correlation of SF-36 and SF-12 Component Scores in Patients With Diabetic Foot Disease.

Authors:  Dane K Wukich; Tresa L Sambenedetto; Natalie M Mota; Natalie C Suder; Bedda L Rosario
Journal:  J Foot Ankle Surg       Date:  2016-03-24       Impact factor: 1.286

Review 2.  Measures of health-related quality of life in diabetes-related foot disease: a systematic review.

Authors:  F R A Hogg; G Peach; P Price; M M Thompson; R J Hinchliffe
Journal:  Diabetologia       Date:  2012-01-14       Impact factor: 10.122

Review 3.  Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy.

Authors:  Prodromos Parasoglou; Smita Rao; Jill M Slade
Journal:  Clin Ther       Date:  2017-05-30       Impact factor: 3.393

4.  [Complex reconstruction with internal locking plate fixation for Charcot arthropathy].

Authors:  F Ramadani; H Härägus; P Radu; K Trieb; S Hofstaetter
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

5.  Midfoot Charcot Neuroarthropathy in Patients With Diabetes: The Impact of Foot Ulceration on Self-Reported Quality of Life.

Authors:  Katherine M Raspovic; Kimberlee B Hobizal; Bedda L Rosario; Dane K Wukich
Journal:  Foot Ankle Spec       Date:  2015-05-08

6.  Genetic variants of ALR (-106C → T /-12C → G) and serum PKC-δ are associated with peripheral neuropathy in Egyptian diabetic patients with impaired handwriting.

Authors:  Shaimaa A Fattah; Moshira Elmadani; Dina M Abo-Elmatty; Mohamed Awadallah; Eman T Mehanna
Journal:  J Diabetes Metab Disord       Date:  2022-02-24

7.  Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre.

Authors:  Aishah Ahmad Fauzi; Tze Yang Chung; Lydia Abdul Latif
Journal:  Singapore Med J       Date:  2016-04       Impact factor: 1.858

8.  Midterm Fate of the Contralateral Foot in Charcot Arthropathy.

Authors:  Felix W A Waibel; Martin C Berli; Viviane Gratwohl; Kati Sairanen; Dominik Kaiser; Laura Shin; David G Armstrong; Madlaina Schöni
Journal:  Foot Ankle Int       Date:  2020-07-22       Impact factor: 2.827

9.  The role of an extended medial column arthrodesis for Charcot midfoot neuroarthropathy.

Authors:  Claire M Capobianco; John J Stapleton; Thomas Zgonis
Journal:  Diabet Foot Ankle       Date:  2010-06-01

10.  Median nerve conduction impairment in patients with diabetes and its impact on patients' perception of health condition: a quantitative study.

Authors:  Jolanta Lewko; Barbara Polityńska; Jan Kochanowicz; Wiesław Zarzycki; Zenon Mariak; Maria Górska; Elżbieta Krajewska-Kułak
Journal:  Diabetol Metab Syndr       Date:  2013-03-25       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.